NORTHWESTERN MUTUAL WEALTH MANAGEMENT CO - INTERCEPT PHARMACEUTICALS IN ownership

INTERCEPT PHARMACEUTICALS IN's ticker is ICPT and the CUSIP is 45845P108. A total of 152 filers reported holding INTERCEPT PHARMACEUTICALS IN in Q1 2022. The put-call ratio across all filers is 0.68 and the average weighting 0.0%.

Quarter-by-quarter ownership
NORTHWESTERN MUTUAL WEALTH MANAGEMENT CO ownership history of INTERCEPT PHARMACEUTICALS IN
ValueSharesWeighting
Q3 2023$5,933
+2584.6%
320
+1500.0%
0.00%
Q2 2023$221
-77.8%
20
-73.0%
0.00%
Q1 2023$994
+302.4%
74
+270.0%
0.00%
Q4 2022$247200.0%0.00%
Q3 2022$0
-100.0%
20
-77.0%
0.00%
Q2 2022$1,000
-50.0%
87
-27.5%
0.00%
Q1 2022$2,000120
+500.0%
0.00%
Q4 2021$0200.0%0.00%
Q3 2021$0200.0%0.00%
Q2 2021$0
-100.0%
20
-85.2%
0.00%
Q1 2021$3,000135
+575.0%
0.00%
Q4 2020$0
-100.0%
20
-85.6%
0.00%
Q3 2020$6,000
-14.3%
1390.0%0.00%
Q2 2020$7,000
+600.0%
139
+595.0%
0.00%
Q1 2020$1,000
-50.0%
200.0%0.00%
Q4 2019$2,000
+100.0%
200.0%0.00%
Q3 2019$1,000
-93.3%
20
-89.2%
0.00%
Q2 2019$15,000
+275.0%
186
+353.7%
0.00%
Q1 2019$4,000
-77.8%
41
-77.5%
0.00%
Q4 2018$18,000
+260.0%
182
+451.5%
0.00%
Q3 2018$5,000
-50.0%
33
-72.5%
0.00%
Q2 2018$10,000
+100.0%
120
+37.9%
0.00%
Q1 2018$5,0000.0%870.0%0.00%
Q4 2017$5,0000.0%870.0%0.00%
Q3 2017$5,000870.00%
Other shareholders
INTERCEPT PHARMACEUTICALS IN shareholders Q1 2022
NameSharesValueWeighting ↓
Chicago Capital Management, LLC 185,781$4,611,56512.16%
Samsara BioCapital, LLC 640,688$11,878,3563.64%
ALPINE ASSOCIATES MANAGEMENT INC. 2,203,295$40,849,0892.14%
Versor Investments LP 378,480$7,017,0191.42%
Magnetar Financial LLC 2,407,209$44,629,6551.14%
DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) 2,077,893$38,524,1360.85%
Fort Baker Capital Management LP 430,600$7,983,3240.74%
EHP Funds Inc. 84,210$1,561,2530.73%
Terrapin Asset Management, LLC 30,000$556,2000.63%
AQR Arbitrage LLC 734,970$13,626,3440.61%
View complete list of INTERCEPT PHARMACEUTICALS IN shareholders